[HTML][HTML] Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - frontiersin.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - europepmc.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
[HTML][HTML] Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo… - Frontiers in …, 2020 - frontiersin.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
[引用][C] Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - cir.nii.ac.jp
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized
Therapies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
Therapies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo… - … of Human Immune …, 2021 - books.google.com
In 2018, according to the GLOBOCAN study, the malignant neoplasms with the highest
mortality were lung (1.76 million deaths), stomach (783,000 deaths), liver (782,000 deaths) …
mortality were lung (1.76 million deaths), stomach (783,000 deaths), liver (782,000 deaths) …
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
[HTML][HTML] Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - europepmc.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …